Physician-patient discussions about prostate-specific antigen test use among African-American men

被引:0
|
作者
Tannor, BB [1 ]
Ross, L [1 ]
机构
[1] Ctr Dis Control & Prevent, Div Canc Prevent & Control, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30341 USA
关键词
physician-patient discussions; PSA test; prostate cancer; men's health;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The purpose of this study was to examine the associations between physician-patient discussions, demographic and health-related variables, and PSA test use. Of the previous studies that examined physic ion-patient discussions about PSA test use, none focused on African-American men. Method Using a sample of African-American men (N=739) aged >= 40 years who had participated in the National Health Interview Survey (NHIS) 2000, we assessed demographic, health status and other variables related to two PSA test use outcomes: 1) had a PSA test within the past year, and 2) had >= 3 PSA tests within the post five years. Results: More than three-fourths (76.6%) of our sample reported that their doctors had discussed with them the advantages and disadvantages of the PSA test before administering it. The bivariate analysis showed a number of variables positively associcted with PSA test use including men aged >= 50, having health insurance coverage and having participated in physician-patient discussions about the test. Discussion: Despite the high percentage of men who had discussions with their doctor, there was a large number of men who had neither heard of nor undergone a PSA test. More efforts should be made by the healthcare community to promote prostate cancer screening education and physician-patient discussions.
引用
收藏
页码:532 / 538
页数:7
相关论文
共 50 条
  • [41] What do men say about diagnostic pathways? From prostate-specific antigen (PSA) test to prostate cancer
    Obertova, Zuzana
    Brown, Charis
    Hodgson, Fraser
    Lawrenson, Ross
    BJU INTERNATIONAL, 2013, 112 : 14 - 14
  • [42] Early detection of prostate cancer in African-American men through use of multiple biomarkers: human kallikrein 2 (hK2), prostate-specific antigen (PSA), and free PSA (fPSA)
    B J Martin
    J A Finlay
    K Sterling
    M Ward
    D Lifsey
    D Mercante
    J M Jainto
    L Martin
    W Rayford
    Prostate Cancer and Prostatic Diseases, 2004, 7 : 132 - 137
  • [43] Aspirin Use and Prostate Cancer among African-American Men in the Southern Community Cohort Study
    Tang, Wei
    Fowke, Jay H.
    Hurwitz, Lauren M.
    Steinwandel, Mark
    Blot, William J.
    Ambs, Stefan
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2021, 30 (03) : 539 - 544
  • [44] Early detection of prostate cancer in African-American men through use of multiple biomarkers: human kallikrein 2 (hK2), prostate-specific antigen (PSA), and free PSA (fPSA)
    Martin, BJ
    Finlay, JA
    Sterling, K
    Ward, M
    Lifsey, D
    Mercante, D
    Jainto, JM
    Martin, L
    Rayford, W
    PROSTATE CANCER AND PROSTATIC DISEASES, 2004, 7 (02) : 132 - 137
  • [45] Intention to be tested for prostate cancer risk among African-American men
    Myers, RE
    Hyslop, T
    Jennings-Dozier, K
    Wolf, TA
    Burgh, DY
    Diehl, JA
    Lerman, C
    Chodak, GW
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2000, 9 (12) : 1323 - 1328
  • [46] Obesity and prostate cancer screening among African-American and Caucasian men
    Fowke, Jay H.
    Signorello, Lisa B.
    Underwood, Willie, III
    Ukoli, Flora A. M.
    Blot, William J.
    PROSTATE, 2006, 66 (13): : 1371 - 1380
  • [47] Prostate cancer: Perceptions and screening behavior among African-American men
    Forrester-Anderson, IT
    FASEB JOURNAL, 2001, 15 (05): : A1002 - A1002
  • [48] Prostate-specific antigen screening among young men in the United States
    Scales, Charles D., Jr.
    Antonelli, Jodi
    Curtis, Lesley H.
    Schulman, Kevin A.
    Moul, Judd W.
    CANCER, 2008, 113 (06) : 1315 - 1323
  • [49] Hemodilution of Prostate-Specific Antigen Levels Among Obese Men Response
    Black, Amanda
    Grubb, Robert L., III
    Andriole, Gerald L., Jr.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2009, 18 (08) : 2343 - 2344
  • [50] Diagnostic value of free prostate-specific antigen among men with a prostate-specific antigen level of <3.0 μg per liter
    Finne, Patrik
    Auvinen, Anssi
    Maattanen, Liisa
    Tammela, Teuvo L.
    Ruutu, Mirja
    Juusela, Harri
    Martikainen, Paula
    Hakama, Matti
    Stenman, Ulf-Hakan
    EUROPEAN UROLOGY, 2008, 54 (02) : 362 - 370